HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
Positive
Neutral
Negative
7 Days
1 Month
3 Months
6 Months
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
876 |
AUTL
876
Autolus Therapeutics
AUTL
$381M
| $1.37 | $19 |
1,287%
upside
| Buy |
28 Dec ‘20
4 years ago |
|
|
877 |
BLRX
877
BioLineRX
BLRX
$15.5M
| $3.65 | $880 |
24,010%
upside
| Buy |
16 Dec ‘20
4 years ago |
|
|
878 |
878
Precigen
PGEN
$1.24B
| $4.13 | $10 |
142%
upside
| Buy |
16 Dec ‘20
4 years ago |
|
|
879 |
879
Savara
SVRA
$665M
| $3.82 | $3 |
21%
downside
| Buy |
15 Dec ‘20
4 years ago |
|
|
880 |
880
Wave Life Sciences
WVE
$1.21B
|
DC
Debjit Chattopadhyay
| $7.48 | $20 |
167%
upside
| Buy |
15 Dec ‘20
4 years ago |
|
881 |
881
Stoke Therapeutics
STOK
$1.2B
| $22.07 | $70 |
217%
upside
| Buy |
15 Dec ‘20
4 years ago |
|
|
882 |
IPHA
882
Innate Pharma
IPHA
$188M
| $2.04 | $11.50 |
464%
upside
| Buy |
14 Dec ‘20
4 years ago |
|
|
883 |
883
Pluri
PLUR
$37.2M
| $4.72 | $9 |
91%
upside
| Buy |
10 Dec ‘20
4 years ago |
|
|
884 |
884
Cibus
CBUS
$68.3M
| $1.41 | $500 |
35,361%
upside
| Buy |
10 Dec ‘20
4 years ago |
|
|
885 |
885
Montrose Environmental
MEG
$1.03B
| $28.52 | $35 |
23%
upside
| Buy |
4 Dec ‘20
4 years ago |
|
|
886 |
886
Kymera Therapeutics
KYMR
$3.09B
| $43.48 | $85 |
95%
upside
| Buy |
4 Dec ‘20
4 years ago |
|
|
887 |
887
Yatra Online
YTRA
$90.5M
| $1.51 | $3 |
99%
upside
| Buy |
3 Dec ‘20
4 years ago |
|
|
888 |
888
Aemetis
AMTX
$143M
| $2.23 | $10 |
348%
upside
| Buy |
3 Dec ‘20
4 years ago |
|
|
889 |
MESO
889
Mesoblast
MESO
$1.86B
| $15 | $80 |
433%
upside
| Buy |
20 Nov ‘20
4 years ago |
|
|
890 |
890
Replimune Group
REPL
$471M
|
RS
Raghuram Selvaraju
| $5.82 | $58 |
897%
upside
| Buy |
10 Nov ‘20
4 years ago |
|
891 |
891
INmune Bio
INMB
$48.1M
|
SR
Swayampakula Ramakanth
| $1.78 | $15 |
743%
upside
| Buy |
9 Nov ‘20
4 years ago |
|
892 |
892
Coherus Oncology, Inc. Common Stock
CHRS
$159M
|
JK
Jason Kolbert
| $1.35 | $32 |
2,270%
upside
| Buy |
6 Nov ‘20
4 years ago |
|
893 |
893
Strata Skin Sciences
SSKN
$7.26M
|
JP
Joseph Pantginis
| $1.60 | $30 |
1,775%
upside
| Buy |
3 Nov ‘20
4 years ago |
|
894 |
894
Solitario Resources
XPL
$75M
| $0.8300 | $0.9000 |
8%
upside
| Buy |
22 Oct ‘20
4 years ago |
|
|
895 |
895
Fortress Biotech
FBIO
$107M
| $3.59 | $150 |
4,078%
upside
| Buy |
12 Oct ‘20
4 years ago |
|
|
896 |
896
EyePoint Pharmaceuticals
EYPT
$941M
| $14.19 | $20 |
41%
upside
| Buy |
9 Oct ‘20
4 years ago |
|
|
897 |
897
Corbus Pharmaceuticals
CRBP
$121M
| $9.53 | $90 |
844%
upside
| Buy |
8 Oct ‘20
4 years ago |
|
|
898 |
PPBT
898
Purple Biotech
PPBT
$1.82M
|
RS
Raghuram Selvaraju
| $0.5925 | $25 |
4,119%
upside
| Buy |
28 Sep ‘20
5 years ago |
|
899 |
899
Tiziana Life Sciences
TLSA
$189M
| $1.85 | $11 |
495%
upside
| Buy |
21 Sep ‘20
5 years ago |
|
|
900 |
900
Alto Ingredients
ALTO
$88.2M
| $1.16 | $16 |
1,279%
upside
| Buy |
16 Sep ‘20
5 years ago |
|